Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος της ογκοκατασταλτικής πρωτεΐνης cylindromatosis (CYLD) σε νεοπλασίες
Abstract
dc:descriptionThe tumor suppressor gene Cyld has recently attracted particular interest due to its involvement in many types of neoplasms including melanoma, hepatocellular carcinoma, breast, head and neck cancers and lung cancer. CYLD protein is a cytoplasmic enzyme with deubiquitinating activity. CYLD selectively hydrolyses polyubiquitin chains, which are not involved in the degradation of proteins through the proteasome, but act as scaffolds for the formation of signaling complexes. The initial objective of this thesis was to investigate the role of the tumor suppressor protein CYLD in the development of renal clear cell carcinoma and colorectal adenocarcinoma, possibly by influencing ubiquitination of proteins that regulate cell growth and survival. For this purpose, CYLD expression, at mRNA and protein levels, was investigated in biopsies from patients with renal clear cell carcinoma and colorectal adenocarcinoma. Reduced CYLD expression was shown in both cancer types, compared to adjacent normal tissue. The second objective was to establish human organoid and short-term 3D colorectal cell cultures from patient biopsies, with the intention to use them as models to investigate molecular mechanisms of colorectal carcinogenesis and develop protocols for personalized therapy. Towards this end, a comparative study was performed regarding the effect of chemotherapeutics on the viability of the two types of 3D cell cultures. The response to chemotherapeutic drugs was similar in long-term and short-term 3D cell cultures, supporting the possibility of using the more simplified protocol of short-term cell cultures as a model in evaluating chemotherapeutic drug sensitivity. The results of the present thesis 1) support the tumor suppressive role of CYLD in renal clear cell carcinoma and colorectal adenocarcinoma and the possibility of using CYLD expression for prognostic and predictive purposes in the future and 2) introduce new tools for the assessment of colorectal cancer sensitivity to chemotherapeutic regimens, for the development of personalized treatment protocols that could be adopted for other types of malignancies.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koutsoumparis, Dimitrios
- Κουτσουμπάρης, Δημήτριος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58534